A study published this week in the peer-reviewed journal Scientific Reports examined the long-term impacts of having shingles ...

Omeros' performance has consistently failed to meet expectations, raising concerns about its future prospects. Read more to ...

The case involved a 59-year-old man with stage IIIA right lung adenocarcinoma who underwent surgery in 2021, followed by ...

Omeros Corporation ( ($OMER) ) has released its Q2 earnings. Here is a breakdown of the information Omeros Corporation presented to its investors.

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy. The FDA is reviewing a nasal spray ...

Narsoplimab for HSCT-Associated Thrombotic Microangiopathy PDUFA date: September 25, 2025 The FDA is reviewing the resubmitted BLA for narsoplimab for the treatment of hematopoietic stem cell ...

3.3 Vascular injury and microangiopathy Diabetes exerts profound detrimental effects on cerebrovascular health, precipitating vascular injury and microvascular pathologies closely associated with ...

Systemic and non-systemic autoimmune diseases in iTTP in the French National Thrombotic Microangiopathy Registry. AID, autoimmune disease; iTTP, immune-mediated thrombotic thrombocytopenic purpura; ...